Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy

One of the major challenges limiting the efficacy of anti–PD-1/PD-L1 therapy in nonresponding patients is the failure of T cells to penetrate the tumor microenvironment. We showed that genetic or pharmacological inhibition of Vps34 kinase activity using SB02024 or SAR405 (Vps34i) decreased the tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Noman, Muhammad Zaeem, Parpal, Santiago, Van Moer, Kris, Xiao, Malina, Yu, Yasmin, Viklund, Jenny, De Milito, Angelo, Hasmim, Meriem, Andersson, Martin, Amaravadi, Ravi K., Martinsson, Jessica, Berchem, Guy, Janji, Bassam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190323/
https://www.ncbi.nlm.nih.gov/pubmed/32494661
http://dx.doi.org/10.1126/sciadv.aax7881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190323/
https://www.ncbi.nlm.nih.gov/pubmed/32494661
http://dx.doi.org/10.1126/sciadv.aax7881

Ejemplares similares